Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery MUC2

Path Created with Sketch.
Go to MUC2 Normal Tissue GalleryGo back to Product Page
Adrenal gland – MUC2 negative adrenocortical adenoma
Adrenal gland – MUC2 negative adrenocortical adenoma
Adrenal gland – MUC2 negative pheochromocytoma
Adrenal gland – MUC2 negative pheochromocytoma
Anal canal – MUC2 negative squamous cell carcinoma
Anal canal – MUC2 negative squamous cell carcinoma
Breast – Invasive breast cancer of no special type (NST) with strong MUC2 staining of virtually all tumor cells
Breast – Invasive breast cancer of no special type (NST) with strong MUC2 staining of virtually all tumor cells
Breast – MUC2 negative invasive breast cancer of no special type (NST)
Breast – MUC2 negative invasive breast cancer of no special type (NST)
Breast – MUC2 negative invasive lobular breast cancer
Breast – MUC2 negative invasive lobular breast cancer
Colon – Colorectal adenocarcinoma with intense MUC2 staining of tumor cells
Colon – Colorectal adenocarcinoma with intense MUC2 staining of tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of most tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of most tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of tumoral goblet cells and of mucus
Colon – Colorectal adenocarcinoma with strong MUC2 staining of tumoral goblet cells and of mucus
Colon – MUC2 negative colorectal adenocarcinoma
Colon – MUC2 negative colorectal adenocarcinoma
Esophagus – Adenocarcinoma with strong MUC2 immunostaining of all tumor cells
Esophagus – Adenocarcinoma with strong MUC2 immunostaining of all tumor cells
Kidney – MUC2 negative clear cell carcinoma
Kidney – MUC2 negative clear cell carcinoma
Kidney – MUC2 negative papillary renal cell carcinoma
Kidney – MUC2 negative papillary renal cell carcinoma
Liver – MUC2 negative hepatocellular carcinoma
Liver – MUC2 negative hepatocellular carcinoma
Lung – Adenocarcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Lung – Adenocarcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Lung – MUC2 negative adenocarcinoma
Lung – MUC2 negative adenocarcinoma
Lymph node – MUC2 negative Hodgkin’s lymphoma
Lymph node – MUC2 negative Hodgkin’s lymphoma
Pancreas – Adenocarcinoma of the papilla Vaterii with strong MUC2 staining of tumoral goblet cells
Pancreas – Adenocarcinoma of the papilla Vaterii with strong MUC2 staining of tumoral goblet cells
Pancreas – Ductal adenocarcinoma with strong MUC2 staining of some tumoral goblet cells
Pancreas – Ductal adenocarcinoma with strong MUC2 staining of some tumoral goblet cells
Pancreas – MUC2 negative neuroendocrine tumor
Pancreas – MUC2 negative neuroendocrine tumor
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong MUC2 positivity of a subset of tumor cells
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong MUC2 positivity of a subset of tumor cells
Prostate – Adenocarcinoma with strong MUC2 staining of a fraction of tumor cells
Prostate – Adenocarcinoma with strong MUC2 staining of a fraction of tumor cells
Prostate – MUC2 negative adenocarcinoma (Gleason 3+3=6)
Prostate – MUC2 negative adenocarcinoma (Gleason 3+3=6)
Salivary gland –MUC2 negative Warthin tumor
Salivary gland –MUC2 negative Warthin tumor
Stomach – Gastric adenocarcinoma (diffuse type) with intense MUC2 positivity of all tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with intense MUC2 positivity of all tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with strong MUC2 positivity of a fraction of tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with strong MUC2 positivity of a fraction of tumor cells
Stomach – MUC2 negative adenocarcinoma
Stomach – MUC2 negative adenocarcinoma
Testis – MUC2 negative seminoma
Testis – MUC2 negative seminoma
Thyroid – MUC2 negative papillary carcinoma
Thyroid – MUC2 negative papillary carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MUC2 immunostaining of all tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MUC2 immunostaining of all tumor cells
Uterus – Endometroid endometrium carcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Uterus – Endometroid endometrium carcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Uterus, cervix – MUC2 negative adenocarcinoma
Uterus, cervix – MUC2 negative adenocarcinoma
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors